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Abstract BTB domain And CNC Homolog 2 (Bach2) is a transcription repressor that actively
participates in T and B lymphocyte development, but it is unknown if Bach2 is also involved in the
development of innate immune cells, such as natural killer (NK) cells. Here, we followed the expression of Bach2 during murine NK cell development, finding that it peaked in immature CD27+CD11b+
cells and decreased upon further maturation. Bach2 showed an organ and tissue-specific expression
pattern in NK cells. Bach2 expression positively correlated with the expression of transcription factor
TCF1 and negatively correlated with genes encoding NK effector molecules and those involved in
the cell cycle. Lack of Bach2 expression caused changes in chromatin accessibility of corresponding
genes. In the end, Bach2 deficiency resulted in increased proportions of terminally differentiated
NK cells with increased production of granzymes and cytokines. NK cell-mediated control of tumor
metastasis was also augmented in the absence of Bach2. Therefore, Bach2 is a key checkpoint
protein regulating NK terminal maturation.
Editor's evaluation
This paper, by identifying the novel factor BACH2s involvement in the generation and maintenance
of NK cells, helps to fully define the NK cell network and will contribute to our understanding or
regulation of NK cell development and function.

Introduction
Natural killer (NK) cells are innate lymphoid cells that have spontaneous cytolytic activity against tumor
cells and virus-infected cells. The development of NK cells occurs in bone marrow (BM) as well as in
secondary lymphoid tissues in both humans and mice. Multipotent hematopoietic stem cells give rise
to common lymphoid progenitors (CLPs) that can differentiate into all types of lymphocytes. NK cell
precursors (NKP) are then derived and later express IL-2R/IL-15R β chain (CD122), defining refined NK
progenitors (rNKp) (Carotta et al., 2011; Fathman et al., 2011). At this stage in the mouse, commitment to NK cell development occurs, followed by the acquisition of the germline-encoded NK receptors NK1.1 and NKp46, and the cells become immature NK cells. Mature NK cells develop when they
gain the expression of DX5 (CD49b), cytotoxic activity, and capacity to produce interferon-γ (IFNγ)
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(Kim et al., 2002). Mature NK cells can be further defined based upon the differential expression
of CD27 and CD11b. Starting from double-negative cells being the most immature cells regarding
their functionality, the cells upregulate the expression of CD27 then CD11b to become CD27+CD11b(CD27+ cells) then CD27+CD11b+ (double-positive) respectively, which undergo homeostatic expansion. Finally, the double-positive cells lose the expression of CD27 and retain expression of CD11b to
become terminally differentiated NK cells (CD11b+ cells) with increased cytotoxic activity (Chiossone
et al., 2009).
The commitment, development, and function of NK cells are distinctly regulated by multiple transcription factors, which are reflected by the expression of many unique surface markers at different
stages of NK cell development. Eomesodermin has been identified as a unique factor required for
NK development, distinct from ILC1s which share many similarities in surface makers with NK cells
(Gordon et al., 2012; Intlekofer et al., 2005). Kruppel-like factor 2 intrinsically regulates NK cell
homeostasis by limiting early-stage NK cell proliferation and guiding them toward trans-presented
IL-15 (Rabacal et al., 2016). IRF8 is required for the effector functions of NK cells against viral infection (Adams et al., 2018). T-bet has a broader function in various cells including T cells, ILC1s, and
NK cells, and positively regulates the terminal maturation of NK cells (Townsend et al., 2004). Similarly, Zeb2 promotes NK terminal differentiation and may function downstream of T-bet (van Helden
et al., 2015). Blimp-1 is expressed throughout NK cell maturation and is required for NK homeostasis (Kallies et al., 2011). TCF1 (encoded by Tcf7) participates in the development of NK cells and
its downregulation is required for NK terminal maturation (Jeevan-Raj et al., 2017). A multi-tissue
single-cell analysis divided NK cells into two major groups based on TCF1 levels: high expression of
TCF1 correlated with genes expressed in immature NK cells including Cd27, Xcl1, and Kit while TCF1
was inversely correlated with the expression of genes involved in effector function such as Gzmb,
Gzma, Ccl5, and Klrg1 (McFarland et al., 2021). Thus, the expression of unique transcription factors
at specific developmental stages of the cells appears to generate distinct gene regulatory circuitries.
These gene regulatory circuits provide ‘fingerprints’ that may be more reliable to reveal the developmental and functional disparities among phenotypically similar cell populations (Collins et al.,
2019). Furthermore, they provide insight into how the development of immune cells, including NK
cells, occurs. Therefore, it is important to further clarify the expression pattern and function of unique
transcription factors for NK cells during their development.
The transcription factor, BTB domain And CNC Homolog 2 (Bach2), was identified as a transcriptional repressor. It forms a heterodimer with Maf family proteins and binds to a DNA motif called
T-MARE (TGCTGA G/C TCAGCA), a Maf recognition element (MARE), to regulate gene expression
(Muto et al., 1998). The regulatory function of Bach2 is mediated through its interaction with the
super-enhancers (SEs), and its aberrant expression is associated with a variety of autoimmune diseases
as well as cancers (Afzali et al., 2017; Marroquí et al., 2014; Roychoudhuri et al., 2016b). In physiological conditions, Bach2 has been shown to participate in cell development, as previously examined
in the adaptive immune system. Bach2 is expressed in CLP and represses genes of myeloid lineage
to promote the development of cells in the lymphoid lineage (Itoh-Nakadai et al., 2014). Bach2
was first shown to be a B cell-intrinsic transcription factor that regulates B cell development through
inhibiting the expression of Blimp-1 (encoded by Prdm1) (Muto et al., 1998; Ochiai et al., 2006). The
rapid upregulation of Blimp-1 mediated by Bach2 deficiency promotes the terminal differentiation of
B cells toward plasma cells even prior to class-switch recombination (CSR) (Muto et al., 2004). Bach2
is also critical in regulating the plasticity of T cells. Under homeostatic conditions, Bach2 maintains
T cells in a naïve state, preventing the generation of effector T cells by inhibiting the expression of
effector molecules downstream of TCR signaling (Roychoudhuri et al., 2016a; Tsukumo et al., 2013).
Bach2 expression is reduced during T cell polarization while higher expression of Bach2 in CD4+ T cell
differentiation promotes the formation of regulatory T cells by repressing genes related to effector
differentiation within helper T cell lineages (Lahmann et al., 2019; Roychoudhuri et al., 2016a;
Roychoudhuri et al., 2013). Regaining the expression of Bach2 after differentiation downregulated
pro-inflammatory signals and differentiation into T cell memory cell lineages (Herndler-Brandstetter
et al., 2018). Thus, the development and function of the adaptive immune cells are critically controlled
by the expression of Bach2 and its associated regulatory circuits.
The role of Bach2 in NK cells has not been characterized. Here, we found that, at steady state,
Bach2 was differentially expressed during NK cell development and terminal maturation. Its deficiency
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in NK cells resulted in a significantly increased expression of genes involved in NK cytotoxicity. Along
with this, NK cells lacking Bach2 expression were more terminally differentiated and demonstrated
better control of tumor metastasis. Thus, Bach2 serves as a checkpoint in the terminal maturation of
NK cells.

Results
Bach2 is expressed at different levels in NK cells at different
developmental stages
To characterize the role of Bach2 in NK cell function, we first examined Bach2 expression during
different stages of NK development. We used a Bach2Flag reporter mouse in which a 3xFlag tag was
fused at the N-terminus of Bach2 protein as described previously (Herndler-Brandstetter et al.,
2018). Bach2 expression was detected in CLPs and expression was relatively reduced in pre-NK
progenitor cells and rNKp (Figure 1A and Figure 1—figure supplement 1A), reflecting the critical
role of Bach2 in the development of lymphoid cells from CLPs (Itoh-Nakadai et al., 2014). During NK
specification downstream of CLP, the expression of Bach2 was at a relatively lower level compared to
CLPs. At the rNKp stage (CD122+CD127+), developing NK cells begin to acquire expression of the NK
cell markers, NK1.1 and NKp46 (Fathman et al., 2011). Bach2 was homogenously expressed by these
NK cells in both the BM and spleen (Figure 1B). At this stage, NK cells further undergo maturation by
acquiring the expression of CD49b (DX5). In both the BM and spleen, Bach2 expression was detected
in both immature (DX5–NK1.1+) and mature (DX5+NK1.1+) NK cells while mature NK cells had even
higher Bach2 expression than the immature NK cells (Figure 1C and Figure 1—figure supplement
1B). We further subdivided NK cell maturation by surface expression of CD27 and CD11b (Chiossone
et al., 2009). Surprisingly, the expression of Bach2 was lowest in the most mature CD27-CD11b+ cells
compared with the other two stages (Figure 1D and Figure 1—figure supplement 1B). This observation was further confirmed by western blot (Figure 1E). Thus, during NK cell terminal differentiation,
Bach2 may function mainly in the relatively immature stages.
At the bulk splenic NK cell population level, the expression of Bach2 inversely correlated with
the age of the mice: 2-week-old mice had the highest expression, and 12-week-old mice had the
lowest expression of Bach2 (Figure 1F). The overall downregulation of Bach2 with age correlated
with changes in the maturation profile of NK cells with age. More than 60% of NK cells were immature
CD27+CD11b- cells with less than 3% of mature CD27-CD11b+ cells in 2-week-old mice while around
40% of NK cells in 12-week-old mice were in the most mature CD27-CD11b+ stage (Figure 1—figure
supplement 1C). Moreover, 2-week-old NK cells showed higher Bach2 levels than their 12-week-old
counterparts in each corresponding NK subset (Figure 1—figure supplement 1D). The effect of
Bach2 on NK cells may not be restricted to splenic NK cells; we also detected Bach2 expression in
NK cells in various different tissues, such as lymph nodes, lung, and liver (Figure 1G). Bach2 showed
similar expression levels in lymph node and liver as compared to spleen while in the lung, the expression was much lower. In summary, our data showed Bach2 expression in NK cells varies at different
developmental stages and shows age and organ-specific patterns.

Bach2 deficiency drives a transition from immature stem-like
phenotype toward mature effector phenotype of NK cells
To further understand the role of Bach2 in NK cell development and function, we generated NK cell-
specific Bach2 conditional knockout mice (referred to as Bach2cKO mice) by crossing Bach2flox/flox mice
with Ncr1iCre mice in which Bach2 was specifically deleted in NKp46-expressing cells. As a control,
Bach2flox/flox mice (referred to as control mice) were used. Examination of Bach2 mRNA showed that
exons 1–2, including the start codon, had been deleted in essentially all Bach2cKO NK cells (Figure 2—
figure supplement 1A), confirming deletion of Bach2 expression in Bach2cKO NK cells. When we
assessed the expression of NK cell inhibitory and activation receptors (Ly49s and NKG2A/CD94), we
did not find any changes in the expressed repertoire of these receptors with Bach2 deficiency except
CD94 showed significant downregulation (Figure 2—figure supplement 1B). However, it was previously reported that genetic deletion of CD94 in NK cells did not affect the development and function
of NK cells (Orr et al., 2010). Thus, a comprehensive analysis was required to better understand the
role of Bach2 in NK cell function.
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Figure 1. BTB domain And CNC Homolog 2 (Bach2) expression at different natural killer (NK) cell developmental
stages by analysis of Bach2Flag knock-in mouse. (A) Histogram plots of Bach2Flag expression (red) in common
lymphoid progenitor (CLP), pre-NK progenitor (pre-NK), and refined NK progenitor (rNKp) as compared to
cells from wild-type (WT) mice (gray fill). The geometric MFI (gMFI) number was indicated in the plot. Summary
of gMFI was shown (n=5 for each group in three independent experiments). (B) Histogram plots of Bach2Flag
expression (red) in NK cell (CD3-CD19-NK1.1+) from bone marrow (BM) and spleen as compared to cells from WT
mice (gray fill). Numbers indicate gMFI and summary of gMFI is shown (n=7 or 9 for each group in three to four
independent experiments). (C) CD3-CD122+ NK cells from BM and spleen were subdivided into iNK (DX5-NK1.1+)
and mNK (DX5+NK1.1+) and analyzed for Bach2Flag expression (red for iNK, blue for mNK) as compared to cells
from WT mice (gray fill). Numbers indicate gMFI and summary of gMFI is shown (n=7 for each group in three to
four independent experiments). (D) Histogram plot of Bach2Flag expression in CD27+CD11b- (red), CD27+CD11b+
(blue), and CD27+CD11b+ (yellow) NK subsets as compared to cells from WT mice (gray fill). Note that WT plot
represents expression of Bach2Flag from CD27-CD11b+ subsets. Numbers indicate gMFI and summary of gMFI is
shown (n=6 for each group in three independent experiments). (E) Splenic NK cells were sorted into CD27+CD11b-,
Figure 1 continued on next page
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CD27+CD11b+ and CD27-CD11b+ subsets. Bach2Flag expression in the subsets was detected using Anti-FLAG
M2-Peroxidase (HRP) antibody by western blot. Expression of Actin was used as an internal control. Two individual
experiments have been done with one mouse each time. (F) Histogram plot of Bach2Flag expression in splenic
NK cell (CD3-CD19-NK1.1+) from mice at 2 weeks’ (red), 5 weeks’ (blue), and 12 weeks’ (orange) age as compared
to cells from WT mice (gray fill). Note that WT plot represents expression of Bach2Flag from 12-week age mice.
Numbers indicate gMFI and summary of gMFI fold change is shown (n=6 or 11 for each group in three to four
independent experiments). (G) Summary of gMFI data for Bach2Flag expression in NK cells from lymph node,
spleen, lung, and liver (n=4 or 6 for each group in three independent experiments). NK cells from lymph node,
spleen, and lung were gated as CD3-CD19-NK1.1+. NK cells from liver were gated as CD3-CD19-NK1.1+DX5+.
Statistical significance was determined by two-way ANOVA (A, C, D, and G), one-way ANOVA, (F) or by Student’s
t test (B). Error bars indicate SD. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. ns, not significant. See Figure 1—
figure supplement 1 for gating strategies.
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. Bach2 expression in different subsets by western blot.
Figure supplement 1. Gating strategy for flow cytometry analysis.

To this end, we performed RNA-seq analysis compared between Bach2-deficient NK cells and
Bach2-sufficient NK cells using sorted splenic NK cells (Figure 2—figure supplement 1C). Principal
component analysis (PCA) revealed significant changes transcriptionally in Bach2-deficient NK cells
as compared to control NK cells (Figure 2—figure supplement 1D). Overall, we found 133 genes
downregulated and 210 genes upregulated in Bach2cKO NK cells as compared to control NK cells
(Bach2cKO versus control) (Figure 2A). The transcripts with decreased expression corresponded to
genes involved in T cell differentiation, cell development, and cell homeostasis pathways (Figure 2A).
These gene signatures suggested that Bach2 controls NK cell differentiation. Specifically, the top 2
downregulated genes were Kit and Tcf7 (Figure 2B), which were previously shown to be responsible
in maintaining the stemness of the T cells (Siddiqui et al., 2019). Regarding NK cells, the loss of Tcf7
expression led to enhanced NK cell terminal maturation (Jeevan-Raj et al., 2017). We also detected
the downregulation of Cd27, Ccr7, and Cd69 (Figure 2B). The downregulation of Ccr7 was previously shown to be correlated with human NK cell differentiation toward effector phenotype (Hong
et al., 2012). On the other hand, the transcripts with elevated expression included genes involved
in the cell cycle, cell proliferation, and inflammatory response pathways (Figure 2A), suggesting a
skewing toward an effector phenotype as a result of Bach2 deficiency. Indeed, among the upregulated
genes were those associated with NK cell effector functions such as Klrg1, Gzmb, Gzmk, and Ccl5
(Figure 2B; Bezman et al., 2012), indicating that lack of Bach2 expression facilitated the differentiation of NK cells toward terminal maturation.
We confirmed the transcriptomics data by quantitative PCR (qPCR) analysis performed on sorted
splenic NK cells from the Bach2cKO and control mice (Figure 2C and D). We detected significantly
lower expression of genes, for example, Tcf7, Kit, and Sox6 in Bach2-deficient NK cells. For other
genes such as Cd69, Sell, and Ccr7, we did not observe significant differences, but they all had a trend
of downregulation in NK cells lacking Bach2 expression (Figure 2C). Regarding genes upregulated in
the RNA-seq analysis, we confirmed Cd39, Klrg1, Gzmb, Klrb1b, and Ccl5 to be increased by qPCR
analysis. However, Cx3cr1 did not reach significance even though it displayed a trend toward upregulation (Figure 2D). Consistent with their transcription level, the proteins encoded by these genes were
changed accordingly with Bach2 deficiency. Kit, CD69, and TCF1 (encoded by Tcf7) were significantly
downregulated in Bach2-deficient NK cells while CD62L (encoded by Sell) did not show difference at
the protein level (Figure 2E and F). On the other hand, CD39, KLRG1, CX3CR1, and Granzyme B were
elevated, consistent with their changes at the RNA level (Figure 2E and F). Although we detected
increased expression of multiple genes involved in cell cycle and proliferation, we did not find a difference in Ki67 expression between Bach2cKO and control NK cells (Figure 2—figure supplement 1E).
Nonetheless, we generally confirmed that our RNA-seq data were reliable to reflect the impact of
Bach2 in regulating the expression of various genes in NK cells.
Next, we asked how Bach2 participated in NK cell biology. It was reported that the enforced Bach2
expression in exhausted CD8+ T cells resulted in the cells becoming exclusively stem-like precursor,
exhausted CD8+ T cells, preventing their further differentiation into terminal exhausted CD8+ T cells
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Figure 2. RNA-seq analysis reveals BTB domain And CNC Homolog 2 (Bach2) deficiency in natural killer (NK) cells promotes the terminal maturation
of NK cells with elevated effector function. (A) Heatmap of differentially expressed genes in NK cells compared between control and Bach2cKO mice
in RNA-seq analysis (FDR < 0.01 and log2 fold change >1.5). Each column represents total splenic CD3-CD19-NK1.1+NKp46+ cells from an individual
mouse. Three biological replicates per group from two individual sorting experiments are shown. The data were analyzed with the Database for
Annotation, Visualization and Integrated Discovery (DAVID) Gene Ontology (GO) analysis for the biological process using the genes differentially
expressed from NK cells between control and Bach2cKO mice. (B) Volcano plot shows differential gene expression between control and Bach2cKO splenic
NK cells. Highlighted are genes discussed in the text. (C and D) RNA expression of indicated genes in Bach2cKO mice or control mice determined by
quantitative PCR (qPCR). Data are shown with four mice per group from two independent experiments. (E) Summary of the percentage of NK cells
expressing the indicated genes in Bach2cKO mice or control mice (n=7 or 8 for each group in three independent experiments). Representative histogram
plots show the expression of indicated protein in NK cells from Bach2cKO mice (red) as compared to NK cells from control mice (gray fill). (F) Summary of
the geometric MFI (gMFI) of indicated gene in total NK cells in Bach2cKO mice or control mice (n=5–8 for each group in three independent experiments).
Representative histogram plots show the expression of indicated proteins in NK cells in Bach2cKO mice (red) as compared to NK cells from control mice
(gray fill). (G and H) Gene set enrichment analysis (GSEA) illustrating enrichment of effector-like (G) and stem-like (H) gene signatures in Bach2cKO and
control splenic NK cells. Statistical significance was determined by Student’s t test. Error bars indicate SD. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
ns, not significant.
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. BTB domain And CNC Homolog 2 (Bach2) deficiency in natural killer (NK) cells resemble activated effector CD8+ T cells.

(Yao et al., 2021). We used gene set enrichment analysis (GSEA) to determine the effect of Bach2 deficiency in NK cells by comparison to the gene signatures of stem-like CD8+ T cells and terminally differentiated effector-like CD8+ T cells (Utzschneider et al., 2016). We found genes upregulated in NK
cells induced by Bach2 deficiency positively correlated with terminal differentiated effector-like gene
signatures (Figure 2G) whereas the genes downregulated showed a stem-like signature (Figure 2H).

Li et al. eLife 2022;11:e77294. DOI: https://doi.org/10.7554/eLife.77294
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Figure 3. Bach2 deficiency results in increased accessible regions in the genome of natural killer (NK) cells. (A) Volcano plot shows the differentially
accessible regions (DARs) and non-DARs between control and Bach2cKO splenic NK cells. (B) De novo motif enrichment at regions of open chromatin
as defined by assay for transposase-accessible chromatin coupled with high throughput sequencing (ATAC-seq) in splenic NK cells from Bach2cKO mice
compared to cells from control mice. Motifs of interest are listed. (C) Genome browser visualization of ATAC-seq peak near Prdm1 and Irf8 gene loci in
NK cells from Bach2cKO mice (red) and control mice (blue). Gray boxes denote differential accessible regions. Red arrows show the location of Bach2-
binding motif. (D and E) Histogram plot shows the expression of Blimp-1 (D) and IRF8 (E) in NK cells from Bach2cKO mice (red) as compared to control
mice (gray fill). Numbers indicate geometric MFI (gMFI). Summary of gMFI is shown (n=5 for each group in three independent experiments). Statistical
significance was determined by Student’s t test. Error bars indicate SD. *p<0.05; ****p<0.0001.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Potential protein interactions between BTB domain And CNC Homolog 2 (Bach2) and differentially regulated transcription
factors in natural killer (NK) cells.

The increased effector gene signatures induced by Bach2 deficiency in NK cells were further validated
by comparing our RNA-seq data with the differential gene expression data generated from naïve and
effector CD8+ T cells (Roychoudhuri et al., 2016a). We found that Bach2-sufficient NK cells displayed
a naïve CD8+ T cell signature (Figure 2—figure supplement 1F) while Bach2-deficient NK cells resembled activated effector CD8+ T cells (Figure 2—figure supplement 1G). These data suggested that
Bach2 expression suppressed terminal differentiation of NK cells by repressing many effector genes.

Bach2 deficiency in NK cells results in altered chromatin accessibility
To understand the mechanisms that drive these unique gene expression programs regulated by Bach2,
we performed assay for transposase-accessible chromatin coupled with high throughput sequencing
(ATAC-seq) to identify active or poised regulatory elements in isolated NK cells from Bach2cKO and
control mice at a genome-wide level. Within the differentially accessible regions (DARs) identified
by ATAC-seq, 564 regions were found to be upregulated and 251 were found to be downregulated
in Bach2-deficient NK cells as compared to Bach2-sufficient NK cells (Figure 3A). Thus, with Bach2

Li et al. eLife 2022;11:e77294. DOI: https://doi.org/10.7554/eLife.77294
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deficiency, the DARs indicated overall increased chromatin accessibility in the genome, consistent
with the putative function of Bach2 as a repressor in NK cells.
The upregulated DARs contained motifs bound by the transcription factors IRF8, Bach1, Bach2,
and AP-1 (Figure 3B). Prior studies indicated IRF8-mediated signaling is required for NK cell maturation and function (Mace et al., 2017), suggesting increased accessibility of IRF8-regulated genes in
Bach2 deficiency thus may result in bias toward NK cell development. Interestingly, we found that the
enriched binding motifs by Bach1, Bach2, Fra2 (Fos-related Antigen 2, an AP-1 transcription factor
subunit), and AP-1 in upregulated DARs all contained a common binding sequence (5’-TGA(C/G)TCA-
3’) (Figure 3B). In CD8+ T cells, Bach2 has been reported to share this common binding sequence
with the AP-1 transcription factor family and compete with AP-1 factors for the access to the target
genes due to the similarity in their binding motifs (Roychoudhuri et al., 2016a). Indeed, we found
the direct target genes of Bach2 in CD8+ T cells, such as Irf8, Ccl3, Ccl4, and Gzmb, showed elevated
expression in Bach2cKO NK cells (Figure 3—figure supplement 1A). Also, there was increased JunD
occupancy in the absence of Bach2 (Figure 3—figure supplement 1B) in NK cells. Thus, these data
suggest that Bach2 in NK cells may also compete for AP-1-binding sites to regulate target genes and
that the deficiency of Bach2 may increase accessibility for AP-1 transcription factors (such as JunD) to
occupy the shared motif.
The motifs enriched in downregulated DARs were mostly TCF/LEF family protein-binding motifs
(Figure 3B), especially the binding motif for TCF1 (encoded by Tcf7) that was also one of the top
downregulated genes in Bach2cKO NK cells (Figure 2E and F). Deficiency of Tcf7 and its downstream
genes promoted the terminal differentiation of NK cells as well as CD8+ T cells (Jeevan-Raj et al.,
2017; Utzschneider et al., 2016). Thus, the reduced accessibility of Tcf7 targeted motifs in the
absence of Bach2 reinforced our findings that Bach2 acted as a checkpoint protein to maintain the
stemness of NK cells.
As a transcription repressor, Bach2 functions through interacting with other transcription factors or
repressing the expression of downstream target genes. For example, Blimp-1 has been widely studied
as a direct target of Bach2 in B cell and T cells (Kometani et al., 2013; Muto et al., 2004; Ochiai
et al., 2006; Roychoudhuri et al., 2013). To explore the transcription factors affected by Bach2 deficiency, we analyzed the differentially expressed genes in RNA-seq and lowered the threshold (FDR
< 0.05 and log2 fold change > 0.2) to include more transcription factors (Figure 3—figure supplement 1C). Most of these differentially expressed transcription factors formed an intricate interaction
network linked by Bach2 shown by the STRING database (Figure 3—figure supplement 1D). Bach2
closely interacted with several transcription factors in the list such as Blimp-1 (encoded by Prdm1),
TCF1 (encoded by Tcf7), BCL6, IRF8, and Fosl2 (Figure 3—figure supplement 1D). Since Bach2
functions as transcription repressor in NK cells, the upregulation of the transcripts of Prdm1 and
Irf8 in Bach2-deficient NK cells indicates they may be targets of Bach2 in wild-type (WT) NK cells
(Figure 3—figure supplement 1C). By ATAC-seq we found that both Prdm1 and Irf8 genes displayed
increased accessibility with Bach2 deficiency (Figure 3C). Furthermore, there were Bach2-binding
motifs in the DARs, suggesting a direct regulatory function of Bach2 on Prdm1 and Irf8 (Figure 3C).
In Bach2-deficient NK cells, Prdm1 and Irf8 were shown to be upregulated at RNA level by both
RNA-seq and qPCR (Figure 2D). However, at the protein level, we failed to detect the corresponding
changes of Blimp-1 compared between NK cells from Bach2cKO and control mice (Figure 3D). While
this may reflect differences in kinetics of mRNA versus protein expression, Blimp-1 has been shown to
be a target of Bach2 in development of functional B cells and T cells (Kometani et al., 2013; Muto
et al., 2004; Ochiai et al., 2006; Roychoudhuri et al., 2013), suggesting another possibility that the
regulatory circuit may be different between Bach2 and Blimp-1 in NK cells. Surprisingly, we found
that IRF8 was significantly upregulated in Bach2-deficient NK cells (Figure 3E). Given that the loss
of IRF8 resulted in impaired terminal maturation of NK cells (Mace et al., 2017), Bach2 may repress
the expression of IRF8 directly or indirectly to affect NK cell development. Overall, our data showed
that Bach2 deficiency increased accessibility across the genome in NK cells and Bach2 may directly
compete for AP-1-binding sites as a repressor or function in an indirect manner through interaction
with other transcription factors.

Bach2 restrained terminal maturation of NK cells
Our genomics and transcriptomics analyses, coupled with the expression pattern of Bach2 during
NK cell development, suggested that Bach2 restricted the terminal maturation of immature NK cells.
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To address this, we analyzed the maturation profile of the NK cells in Bach2cKO and control mice. In
the BM, we did not observe any significant difference between control and Bach2cKO mice regarding
the frequency of the CD27+ cells or CD11b+ cells (Figure 4A) although total NK cell numbers were
reduced in Bach2cKO mice (Figure 4B). We detected an altered maturation profile of NK cells in the
spleen of Bach2cKO mice with more cells having the mature NK cell phenotype (CD11b+) and fewer
cells at the immature DP stage as compared to control mice (Figure 4C). However, the total number
of NK cells was unchanged in the spleen (Figure 4D). As we previously showed, the expression of
KLRG1, a marker of terminally mature splenic NK cells was also increased at the population level
(Figure 2E), further confirming biased development into terminally mature NK cells. To confirm the
lack of influence of T cells and B cells on NK cell development and maturation, we evaluated NK cells
in germline Bach2-deficient mice on the Rag1-/- background. The maturation of NK cells was analyzed
in both Bach2-/- Rag1-/- (referred to as Bach2-/-) mice and Rag1-/- (referred to as WT) mice. Similar to
the results presented in Bach2cKO mice, we found the frequency of CD27+CD11b+ NK cells was significantly reduced while the frequency of CD27-CD11b+ NK cells was markedly increased in both BM
(Figure 4—figure supplement 1A) and spleen (Figure 4—figure supplement 1B) in Bach2-/- mice. In
agreement, the expression of KLRG1 was upregulated and we also found more cells (~80%) expressing
KLRG1 in Bach2-/- mice compared to Bach2-sufficient mice (~50%) (Figure 4—figure supplement 1C).
We also examined NK maturation profiles in other tissues. We did not find significant changes in NK
cell maturation in lymph nodes (Figure 4E) whereas a reduced NK cell number was found (Figure 4F).
In liver, we observed a similar pattern as we found in spleen, with increased terminal maturation of
NK cells (Figure 4G) but we failed to see changes in NK cell number (Figure 4H). Interestingly, lung
displayed a unique profile of NK maturation with most of the NK cells falling into the most mature NK
subset in control mice (Figure 4I). Even while biased toward this subset, we still detected an increased
percentage of CD27-CD11b+ cells with Bach2 deficiency (Figure 4I). Different from other tissues, we
also detected more NK cells in lung from Bach2cKO mice (Figure 4J), suggesting a preferential homing
of terminally matured NK cells into the lung. Taken together, these data indicate that NK cells were
skewed toward the most mature subset in Bach2-deficient mice as compared to Bach2-sufficient mice,
with a concomitant decrease in immature NK cells.

B16 tumor growth and metastasis is controlled by NK cells with Bach2
deficiency
Since Bach2-deficient NK cells showed skewed differentiation with increased expression of effector
molecules, especially cytotoxic genes and increased cell numbers in lung, we evaluated whether mice
lacking Bach2 in NK cells would result in better control of tumor lung metastases in vivo. We injected
2.5×105 B16F10 cells intravenously into Bach2cKO or control mice and evaluated tumor metastases 2
weeks later by counting the black colonies formed in lungs. The lung metastases of B16F10 tumors in
Bach2cKO mice were dramatically reduced compared to control mice (Figure 5A and B). This control
of tumor metastases was NK cell-dependent because both Bach2cKO mice and control mice displayed
a similar number of metastatic tumor colonies when NK cells were depleted with anti-NK1.1 (PK136)
(Figure 5A and B). These data suggested that Bach2 deficiency plays a role in controlling tumor
metastasis by NK cells.
To determine if Bach2 deficiency in NK cells resulted in better direct killing of B16F10 cells, we
performed in vitro tumor killing assays with B16F10 cells. However, we did not see any difference in
killing B16F10 cells between Bach2cKO and control NK cells (Figure 5—figure supplement 1A). We
also assessed IFNγ production in response to various stimulations including anti-NK1.1, IL-15, and
IL-12 plus IL-18 on splenic NK cells. We did not detect any difference with or without Bach2 expression in NK cells (Figure 5—figure supplement 1B). Although splenic NK cells lacking Bach2 showed
increased Granzyme B expression, lung NK cells displayed similar levels of Granzyme B expression
between control and Bach2cKO mice at steady state (Figure 5—figure supplement 1C). Since it had
been shown that NK cells effectively cleared disseminated tumor cells from the lung within 24 hr of
tumor inoculation (Ichise et al., 2022), we tested the NK function in vivo in the lung 24 hr after tumor
injection in Bach2cKO mice. We observed increased NK cells in the lung in Bach2cKO mice (Figure 5C)
similar to the phenotype at steady state (Figure 4J). We did not detect more proliferating NK cells
in the lungs in Bach2cKO mice after tumor injection (Figure 5—figure supplement 1D), suggesting
that NK cell migration may cause the increased lung NK cell numbers in Bach2cKO mice. NK cells also
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Figure 4. Bach2 deficiency increases natural killer (NK) cells with terminally differentiated phenotype.
Representative flow cytometry plots show NK cells (CD3-CD19-NK1.1+NKp46+) separated into maturation stages by
CD27 and CD11b expression. The percentage of CD27+CD11b-, CD27+CD11b+, CD27-CD11b+ NK cells among all
NK cells (left, representative flow plots; right, bar graph summary) from bone marrow (BM) (A), spleen (C), lymph
node (E), liver, (G) and lung (I) in Bach2cKO mice and control mice were plotted (n=5–8 for each group from three
independent experiments). Note that NK cells from liver were gated on CD3-CD19-DX5+NK1.1+NKp46+. Summary
of the total number of NK cells from BM (B), spleen (D), lymph node (F), liver (H), and lung (J) in Bach2cKO mice and
control mice were plotted (n=5–8 for each group from three independent experiments). Statistical significance was
determined by two-way ANOVA (A, C, E, G, and I) or by Student’s t test (B, D, F, H, and J). Error bars indicate SD.
*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. ns, not significant.
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. BTB domain And CNC Homolog 2 (Bach2) deficiency results in a more mature phenotype.
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Figure 5. Lack of BTB domain And CNC Homolog 2 (Bach2) expression in natural killer (NK) cells suppresses B16F10 tumor metastasis.
(A) Representative picture of lung metastatic nodules in Bach2cKO mice and control mice under steady-state or anti-NK1.1 (PK136) depletion.
(B) Summary of the number of B16F10 metastatic nodules in lung from Bach2cKO and control mice with or without anti-NK1.1 (PK136) depletion. Data
were pooled from three to four independent experiments with a total of six to fifteen mice per group. (C–E) 2×105 B16F10 cells were intravenously
injected to Bach2cKO mice or control mice. After 24 hr, NK cells from lung were harvested and analyzed for total number (C), maturation by CD27 and
CD11b (D), and the percentage of KLRG1+ NK cells (E). Average NK cell numbers were calculated for each experiment with one to two mice per group,
and data were pooled together from five independent experiments (C). Data were pooled from three independent experiments with five mice per
group (D and E). Statistical significance was determined by Student’s t test (B and E), Student’s t test (paired t test) (C), or by two-way ANOVA (D). Error
bars indicate SD. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. ns, not significant.
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. Natural killer (NK) cell effector function was unchanged with BTB domain And CNC Homolog 2 (Bach2) deficiency.

displayed a biased maturation profile toward CD27-CD11b+ NK cells (Figure 5D) as well as increased
proportion of KLRG1+ cells (Figure 5E) in Bach2cKO mice compared to control mice after tumor challenge. Studies have shown that the terminally developed CD27lowKLRG1+CD11bhigh NK subsets are
crucial in clearing the early metastatic colorectal carcinoma in mice (Malaisé et al., 2014). Thus,
the increased NK cell number with higher percentage of mature CD27-CD11b+ subset with elevated
KLRG1 expression may be responsible for the lower metastatic colonies in the lung in Bach2cKO mice.
In summary, NK cells in Bach2-deficient mice are more efficient in controlling tumor progression and
metastasis in the lung.

Discussion
Here, we found that Bach2 is highly expressed in functional immature NK cells (CD27+ cells) and gradually downregulates its expression at the terminal stage of NK maturation (CD11b+ cells). In line with
this, we demonstrated that Bach2 deficiency caused a biased NK cell development toward terminal
differentiation in an NK cell-
intrinsic manner. Bach2-
deficient NK cells also displayed increased
cytotoxic gene expression and chromatin accessibility and were more potent in controlling tumor
metastases.
Bach2 plays a critical role in the development of lymphoid cells: its presence in CLP repressed the
expression of genes important for myeloid cells, promoting the development of T and B cells (Itoh-
Nakadai et al., 2014). However, in the BM, the expression of Bach2 increased after commitment
of stem cells to the B cell lineage with its expression high in pre-pro B cells, pro-B cells, pre-B cells,
and immature B cells. Bach2 served as a checkpoint protein in B cells that inhibited the expression
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of the immunoglobulin heavy chain of activated p53 by competing with BCL6 for functional VDJ
rearrangements (Muto et al., 1998; Swaminathan et al., 2013). Bach2 also suppressed the differentiation of activated B cells to plasma cells by inhibiting the expression of Blimp-1 (encoded by Prdm1
gene), which allowed CSR and somatic hypermutation to take place before becoming plasma cells
(Kometani et al., 2013; Muto et al., 2004; Ochiai et al., 2006). Here, we also detected a relatively
high expression of Bach2 in CLP but there was a reduction in pre-NK progenitors and refined NK
progenitors. We showed that Bach2 started to gain its expression in NK cells after the acquisition
of germline-encoded NK receptors such as NK1.1 and NKp46, a stage when NK cells displayed an
effector program. The differential expression pattern of Bach2 in the early stage between NK cell
development and B cell development indicated a divergent trajectory of CLP for the commitment of
B cells and NK cells.
Bach2 was specifically highly expressed in CD27+ cells but not in CD11b+ terminal differentiated
cells. Interestingly, maturing NK cells upregulate CD27 transiently followed by the upregulation of
CD11b and KLRG1 (Chiossone et al., 2009; Huntington et al., 2007). During this transition, NK
cells lose their homeostatic expansion capacity but acquire cytotoxic activity (Chiossone et al., 2009;
Huntington et al., 2007), suggesting the main role of Bach2 is to suppress the functional development of the most mature NK cells. Indeed, when we examined the differential gene expression and
genome accessibility in the context of Bach2 deficiency specifically in mature NK cells, we detected
an upregulation of a series of genes related to cell proliferation, immune effector molecules, and cell
apoptosis. In contrast, genes associated with cell development and homeostasis were downregulated
with Bach2 deficiency, suggesting that Bach2 might be required for NK cell self-renewal at steady
state.
The Bach2-regulated genes we detected with differential expression patterns in NK cells correlated
very well with the gene signatures observed in CD8+ T cells, their cytotoxic counterparts in the adaptive immune system. One of the genes, Tcf7, was particularly interesting and may be important for the
mechanism of the regulation of NK development by Bach2. Tcf7 (encoding TCF1) is highly expressed
in naïve T cells, decreased in effector T cells, and regained its expression in memory cells, showing
its role in maintaining pluripotency of the T cells (Willinger et al., 2006; Zhao et al., 2010). Similarly,
Bach2 also maintained T cells in a naïve status under homeostatic conditions, preventing the generation of effector T cells through inhibiting the expression of effector molecules downstream of TCR
signaling (Roychoudhuri et al., 2016a; Tsukumo et al., 2013). On the other hand, TCF1 was recently
shown to be a hallmark of stem-like precursor exhausted CD8+ T cells with self-renewal capability
and can differentiate into terminal effector-like exhausted CD8+ T cells which lacked TCF1 expression (Utzschneider et al., 2020). It was shown that Bach2 also played a positive role in maintaining
the pool of these stem-like precursors exhausted CD8+ T cells as enforced overexpression of Bach2
resulted in the cells retaining this stem-like condition while knockout of Bach2 led to terminal differentiation of the cells (Yao et al., 2021). Our data in NK cells also showed the link between Bach2 and
TCF1 as Bach2 deficiency caused downregulation of TCF1 transcription. More importantly, TCF1 has
been previously shown to participate in NK development and its downregulation was required for NK
cell terminal maturation (Jeevan-Raj et al., 2017), suggesting that Bach2 and TCF1 may interact in
regulating NK cell development.
Given that Bach2 is a transcriptional repressor through its interaction with SEs and TCF1 was downregulated in the absence of Bach2, it is possible that Bach2 may indirectly regulate TCF1 expression.
Although RNA-seq, ATAC-seq, and flow cytometry all showed a trend for the downregulation of TCF1,
it is still unknown how TCF1 is regulated by Bach2. Unlike CD8+ T cells in which Bach2 may antagonize
RUNX3 to induce TCF1 expression (Yao et al., 2021), we did not detect changes in RUNX3 expression in NK cells, indicating a different regulatory circuit between Bach2 and TCF1 in NK cells. Another
potential interaction between Bach2 and TCF1 is through BCL6. We found that BCL6 was downregulated in Bach2cKO NK cells while BCL6 was recently reported to directly bind the regulatory region of
Tcf7 and promoted its expression in memory CD8+ T cells (Liu et al., 2019), indicating that Bach2 can
induce BCL6 expression (a similar positive correlation was found in B cells) (Huang et al., 2014) and
promote TCF1 expression. Thus, the pathways for Bach2 to regulate TCF1 may incorporate pathways
shared by both B cells and T cells but since we only detected a minor decrease of TCF1 at the protein
level in Bach2-deficient NK cells, to what extent Bach2-TCF1 regulation impacts NK development
requires further investigation.
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Regarding how Bach2 functions in NK cells as compared to other lymphoid cells, Blimp-1 was
uncovered to be the target of Bach2 in both B cells and T cells to regulate cell differentiation and
function (Ochiai et al., 2006; Roychoudhuri et al., 2013). Regulome analysis of human NK cells
also proposed that Bach2-mediated gene suppression relied upon inhibiting Blimp-1 expression, and
Blimp-1 repressed the TCF1-LEF1-MYC-induced homeostatic expansion of NK cells (Collins et al.,
2019). However, in our data, we did not detect changes in Blimp-1 protein expression except for a
slight upregulation at the mRNA level in Bach2-deficient NK cells, indicating Prdm1 is not the major
target of Bach2 in regulating NK cell differentiation. Interestingly, IRF8 may be potentially regulated
by Bach2 to promote NK cell maturation. IRF8 expression was significantly upregulated in Bach2-
deficient NK cells and the chromatin at the Irf8 locus showed increased accessibility. Bach2 may
repress IRF8 transcription directly since we found Bach2-binding motifs within the intron region. On
the other hand, Bach2 may interact with other transcription factors to regulate IRF8 expression indirectly. A recent study shows that there are three MafK-binding sites within the Irf8 locus (Fourier
et al., 2020). As Bach2 has been shown to act together with MafK to bind to the MAREs and negatively regulate B cell function (Muto et al., 1998), it is possible that a similar mechanism may occur in
NK cell regulation by Bach2.
It is of great interest to explore other gene regulatory circuits that control NK cell developmental
stages. While Bach2 negatively regulates downstream factors to restrain NK terminal differentiation,
the expression and function of Bach2 are expected to be tightly regulated by upstream transcription
factors. Studies in B cells showed that the mammalian target of rapamycin complex 2 (mTORC2)
inhibits FoxO1 to reduce Bach2 mRNA expression (Tamahara et al., 2017). Interestingly, FoxO1 was
found to directly bind within and proximal to the Bach2 gene locus in CD8 T cells (Delpoux et al.,
2021). Upon T cell activation, FoxO1 induces the Bach2 transcripts to compete with AP-1 factors
for AP-1-binding sites (Delpoux et al., 2021). In NK cells, FoxO1 suppresses NK cell maturation
by repressing T-bet (Deng et al., 2015) and mTORC2 was also found to regulate T-bet expression
through AktS473- FoxO1 (Yang et al., 2018). When mTORC2 was knocked out, the expression of T-bet
was impaired. However, Bach2 was upregulated at the mRNA level as a target of FoxO1 (Yang et al.,
2018). Together, these data suggest that Bach2 may be the downstream target of an mTORC2-AKTFoxO1 axis in NK cells, which will need further evaluation.
Human NK cells encompass two major subsets, known as CD56dim and CD56bright NK cells. CD62L
(encoded by Sell) and CCR7 were shown to be highly expressed by CD56bright NK cells and drove their
migration to secondary lymphoid tissues (Campbell et al., 2001; Frey et al., 1998). CD56bright NK cells
also expressed high levels of c-Kit for their homeostatic proliferation (Matos et al., 1993). In agreement with this, Sell, Ccr7, and Kit genes were all downregulated in Bach2-deficient NK cells in our data
in mice. In contrast, CD56dim NK cells displayed a high density of CX3CR1 for the migration to tissues
and higher cytotoxic activity by increased expression of perforin and various granzymes (Campbell
et al., 2001), which resembled our Bach2-deficient NK phenotypes in mice. More importantly, Bach2
has been demonstrated to be highly expressed by CD56bright NK cells and with low expression in
CD56dim NK cells (Holmes et al., 2021). In murine NK cells, Bach2 also shows preferential expression
in immature CD27+ subsets compared to mature CD11b+ subsets. Therefore, the function of Bach2
may be conserved between human and mouse for its regulatory circuitries but this still needs further
exploration.
NK cells are currently being studied in clinical trials as potential targets for cancer immunotherapy.
Our study shows that, in mice, Bach2 functions as a checkpoint to restrain NK cell cytotoxicity and
Bach2 deficiency leads to enhanced NK cell-mediated control of B16 melanoma metastases. Studies
in humans have also suggested that Bach2 may play a similar role in human NK cells (Collins et al.,
2019). As a result, our study suggests that Bach2 may be a novel target for checkpoint inhibition of
NK cells for cancer immunotherapy.

Materials and methods
Mice and cell line
WT C57BL/6 (B6) mice and Rag1-/- mice were purchased from The Jackson Laboratories. Bach2Flag
knock-in mice have been described before (Herndler-Brandstetter et al., 2018) as have Bach2flox/flox
mice (Kometani et al., 2013). NK cell Bach2 conditional knockout mice were generated by crossing
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Bach2flox/flox mice with Ncr1iCre mice (Narni-Mancinelli et al., 2011) from Eric Vivier (CNRS-INSERM-
Universite de la Mediterranee, Marseille, France). ES cells for Bach2-/- (Bach2tm1e) mice were purchased
from the EuComm program. The mice were derived from ES clone EPD0689_1_H03, ES line JM8A3.
N1. Animal experiments were performed with 6- to 12-week male or female mice, except for those
specifically indicated. The B16F10 cell line was bought from ATCC (Catalog# CRL-6475). The identity
was confirmed by ATCC and there is no mycoplasma contamination.

Antibodies and flow cytometry
The following antibodies and reagents were purchased from eBioscience (San Diego, CA): anti-CD127
(A7R34), anti-CD3e (145–2C11), anti-CD19 (eBio1D3), anti-CD49b (DX5), anti-NK1.1 (clone PK136),
anti-CD27 (LG.TF9), anti-CD11b (M1/70), anti-NKp46 (29A1.4), anti-CD39 (24DMS1), anti-Granzyme
B (NGZB), anti-IFNγ (XMG1.2), anti-Ly49A (eBio12A8), anti-Ly49D (eBio4E5), anti-Ly49E/F (CM4), anti-
Ly49I (YLI-90), anti-CD94 (18d3), anti-NKG2A (16a11),anti-TER-119 (TER-119), anti-CD62L (MEL-14),
anti-CD117 (2B8), anti-IRF8 (V3GYWH), anti-Blimp-1 (5E7), anti-Ki-67 (SolA15), Fixable Viability Dye
eFluor 506. The following antibodies were purchased from BD Biosciences (San Diego, CA): anti-
CD244.2 (2B4), anti-TCF-7/TCF-1 (S33-966), anti-Ly49F (HBF-719), anti-CD122 (TM-β1), anti-CD69
(H1.2F3), anti-Ly-49G2 (4D11). The following antibodies were purchased from Biolegend (San Diego,
CA): anti-CD135 (A2F10.1), anti-DYKDDDDK tag (L5), anti-KLRG1 (MAFA) (2F1/KLRG1), anti-CX3CR1
(SA011F11). Anti-Ly49H (3D10) and anti-Ly49C (4LO33) were produced in-house. BM or spleen cells
were treated with RBC lysis buffer to remove erythrocytes. Then, cells were treated with 2.4G2 (anti-Fc
RII/III) hybridoma supernatants (produced in-
house) to block Fc receptors. Surface staining was
performed on ice in FACS staining buffer (1% BSA, 0.01% NaN3 in PBS). The labeling of BM progenitor populations has been described before (Jeevan-Raj et al., 2017). Lineage-positive cells were
labeled by a cocktail of biotin-conjugated anti-CD3e, CD19, NK1.1, CD11b, Gr-1, Ter-119 antibodies
(eBioscience). The resulting lineage-negative cells (Lin-) were further stained to identify CLP, pre-NK
progenitor, and rNK progenitor as indicated. For intracellular staining of Bach2Flag, TCF1, Blimp-1, and
IRF8, the Foxp3 transcription factor staining buffer set (BD Biosciences) was used according to the
manufacturer’s protocols. For intracellular staining of GzmB and IFNγ, the intracellular fixation and
permeabilization buffer set (BD Biosciences) according to the manufacturer’s protocols, samples were
collected by FACS Canto (BD Biosciences), and data were analyzed by FlowJo.

Western blot
NK cells from spleen were enriched with the EasySep Mouse NK cell isolation kit (STEMCELL Technologies, Vancouver, BC) according to the manufacturer’s instructions. Enriched NK cells were then labeled
by indicated surfaced markers and sorted into different subsets. Sorted cells were lysed in RIPA buffer
in the presence of Halt Protease Inhibitor Cocktail (Thermo Fisher Scientific, Catalog# 78429, Waltham,
MA) on ice. Lysates were denatured in ×2 Laemmli sample buffer (Bio-Rad, Hercules, CA) and resolved
by SDS-PAGE (Bio-Rad, 4561034). Proteins were transferred to nitrocellulose membranes and probed
with indicated antibodies. Anti-FLAG M2-Peroxidase (HRP) (A8592) was purchased from Sigma (St
Louis, MO). Beta-Actin Rabbit antibody (4967S) and anti-rabbit IgG HRP-linked antibody (7074S) were
purchased from Cell Signaling (Danvers, MA).

RNA-seq and qPCR
NK cells from the spleen were enriched by the EasySep Mouse NK cell isolation kit (STEMCELL Technologies) according to the manufacturer’s instructions. Enriched cells were then sorted into CD3-CD19NK1.1+NKp46+ cells. RNA was purified by PureLink RNA Mini Kit (Invitrogen, 12183018A). RNA-seq
was performed by the Genome Technology Access Center at Washington University School of Medicine. NovaSeq 6000 was used for sequencing. RNA-seq reads were then aligned to the Ensembl
release 76 primary assembly with STAR v2.5.1a (Dobin et al., 2013). Gene counts were derived from
the number of uniquely aligned unambiguous reads by Subread/featureCount v1.4.6-p5 (Liao et al.,
2014). Low expressing genes were filtered with the criteria of cmp > 1 in at least three samples. Two
outliers were removed. RUVr method (k=1) in RUVseq R package was used to remove batch effect.
Differential gene expression was determined using the EdgeR R package with FDR < 0.01 and log2
fold change > 1.5 as the thresholds. Heatmaps were generated with pheatmap R package. PCA was
performed by prcomp function of R. Gene set enrichment pathways analysis was done using the
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Broad Institute’s GSEA software by comparing signature databases from GSE83978 and GSE77857.
For qPCR, cDNA was synthesized by ProtoScript II Reverse Transcriptase (NEB, M0368S, Ipswich).
Pre-designed primers for indicated genes were obtained from IDT. Quantitative real-time PCR was
performed by PowerUp SYBR Green Master Mix Kit (Thermo Fisher Scientific) on a StepOnePlus real-
time PCR system (Thermo Fisher Scientific). Relative gene expression was normalized to beta-actin
and calculated by the ΔΔCt method.

ATAC-seq and analyses
NK cells from the spleen were enriched by the EasySep Mouse NK cell isolation kit (STEMCELL Technologies) according to the manufacturer’s instructions. Enriched cells were then sorted into CD3CD19-NK1.1+NKp46+ cells. ATAC-seq libraries were generated using the omni-ATAC protocol (Corces
et al., 2017); 150K NK cells were used as input for each sample. All ATAC libraries were barcoded,
pooled, and sequenced using 75 bp paired-end read to a depth of at least 30 million. Quality control
of ATAC data was performed using the AIAP pipeline (v1.1) (Liu et al., 2021). All libraries received the
highest possible score (total score = 10). ATAC peaks for each sample were called as a part of the AIAP
pipeline, using macs2 with FDR cutoff at 0.01. After manual inspection of the peaks called, we further
filtered the resulting narrowPeak files for peaks with −log10FDR≥9. To call DARs, we merged all overlapping peaks to create a union peak set. We then formed a peak-sample matrix with each entry corresponding to the number of Tn5 insertion sites in each peak for each sample. Tn5 insertion sites were
also calculated as a part of the AIAP pipeline. DARs were called using DESeq2 (v1.26.0) (Love et al.,
2014) with default parameters with the cutoff of ‘log2 fold change≥0.5 and FDR≤0.05’. For motif
enrichment in DARs, we separately generated background peaks for up (Bach2cKO > Control) and
down (Control > Bach2cKO) DARs. For each DAR, we selected without replacement its 10 closest non-
DARs in the Euclidean space constructed from WT samples as background peaks. We used HOMER
(v4.11.1) (Heinz et al., 2010) for motif enrichment in DARs relative to background peaks (findMotifsGenome.pl up_DAR.bed mm10.fa out_dir -bg up_DAR_background.bed -nomotif -size given).
To annotate Bach2 motifs in DARs, we downloaded the Bach2 motif (MA1101.1) from the JASPAR
(Castro-Mondragon et al., 2022) motif database, and used FIMO (v5.4.1) (Grant et al., 2011) to scan
DARs for the presence of this motif with a p-value cutoff at 0.0005. ATAC signal was visualized using
WashU Epigenome Browser (Li et al., 2022).

B16F10 metastasis assay
B16F10 cells were maintained in R10 (RPMI 1640 medium [Gibco] containing 10% FBS, 1% penicillin/
streptomycin, 1% L-glutamine, 55 μM 2-mercaptoethanol). Before injection, 2.5×105 B16F10 cells
were resuspended in 300 µl PBS, and intravenously injected into mice. After 14 days, tumor metastasis
was evaluated by counting the black colonies formed in the lung under a dissecting microscope with
a blinded analysis whereby the investigator counting the nodules was unaware of the experimental
conditions.

Cell isolation and stimulation
Single-cell suspensions were obtained from spleen, BM, mesenteric lymph node, liver, and lung as
previously described (Sojka et al., 2014). Additionally, in order to obtain cells from lung, the tissue
was subjected to collagenase (Liberase Blendzyme III, Roche), hyaluronidase (Sigma), and DNase I
(grade II, Roche) for digestion (Wu et al., 2015). Splenocytes were stimulated with 1 μg/ml precoated
antibody against NK1.1 (PK136), 100 ng/ml IL-15 (PeproTech), or 20 ng/ml IL-12 p70 (PeproTech) plus
20 ng/ml IL-18 (MBL, Woburn, MA). BFA (Biolegend) was added after 1 hr. After 6 hr of stimulation,
cells were harvested for IFNγ detection by flow cytometry.

NK cell cytotoxicity assay
Lymphokine-activated killer (LAK) cells were produced by passing splenocytes through nylon wool
column then cultured in R10 with 800 U/ml IL-2 supernatant (homemade) for 7 days. Adherent LAK
cells from day 4, day 6, and day 7 were checked for the purity by flow cytometry for CD3-CD19-NK1.1+
cells. B16F10 cells were labeled by 40 µM calcein-AM (Biolegend) as target cells (Neri et al., 2001).
LAK cells were then co-cultured with target cells at different effector to target ratios for 4 hr. Target
cells alone were treated with 2% Triton for maximal release. Cell-free supernatants were harvested and
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fluorescence (excitation: 488 nm; emission: 520 nm) determined on Synergy H1 plate reader (Center
for Human Immunology and Immunotherapy Programs, Washington University School of Medicine).
The specific killing efficiency was calculated as {(experimental release – spontaneous release)/(maximal
release – spontaneous release)} * 100.

Statistical analysis
Statistical analyses were performed using GraphPad Prism 9 software. The statistical test used is
stated in the figure legends. Data are presented as mean ± SD as stated in the figure legends. Statistical significance was determined as indicated with p<0.05 was considered statistically significant.
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Appendix 1
Appendix 1—key resources table
Reagent type (species) or
resource
Designation

Source or
reference

Identifiers

Strain, strain background
(Mus musculus)

C56BL/6J, wild type

The Jackson
Laboratories

RRID:IMSR_JAX:000664

Strain, strain background
(Mus musculus)

RAG1-/-, wild type

The Jackson
Laboratories

RRID:IMSR_JAX:034159

Strain, strain background
(Mus musculus)

Bach2Flag

Tomohiro Kurosaki

Strain, strain background
(Mus musculus)

Bach2fox/flox, flox-Bach2

Tomohiro Kurosaki

Strain, strain background
(Mus musculus)

NKp46iCre; Ncr1tm1.1(icre)Viv

Eric Vivier

MGI:5308410

Strain, strain background
(Mus musculus)

Bach2-/-, Bach2tm1e

EuComm

Bach2tm1e(EUCOMM)Wtsi

Cell line (Mus musculus)

B16F10

ATCC

CRL-6475

Antibody

Anti-Mouse CD127 PE-Cyanine7, rat
monoclonal
eBioscience

Catalog# 25-1271-82

Flow cytometry (1:100)

Antibody

Anti-Mouse CD3e FITC, armenian
hamster monoclonal

eBioscience

Catalog# 11-0031-85

Flow cytometry (1:100)

Antibody

Anti-Mouse CD19 FITC, rat
monoclonal

eBioscience

Catalog# 11-0193-86

Flow cytometry (1:100)

Antibody

Anti-Mouse CD49b (Integrin α2)
FITC, rat monoclonal

eBioscience

Catalog# 11-5971-85

Flow cytometry (1:100)

Antibody

Anti-Mouse NK1.1 PE-Cyanine7,
mouse monoclonal

eBioscience

Catalog# 25-5941-82

Flow cytometry (1:100)

Antibody

Anti-Mouse CD27 APC, armenian
hamster monoclonal

eBioscience

Catalog# 17-0271-82

Flow cytometry (1:100)

Antibody

Anti-Mouse CD11b eFluor 450, rat
monoclonal

eBioscience

Catalog# 48-0112-82

Flow cytometry (1:100)

Antibody

Anti-Mouse NKp46 PerCP-eFluor
710, rat monoclonal

eBioscience

Catalog# 46-3351-82

Flow cytometry (1:100)

Antibody

Anti-Mouse CD39 PE, rat
monoclonal

eBioscience

Catalog# 12-0391-82

Flow cytometry (1:100)

Antibody

Anti-Mouse Granzyme B PE, rat
monoclonal

eBioscience

Catalog# 12-8898-80

Flow cytometry (1:100)

Antibody

Anti-Mouse IFNγ gamma eFluo450,
rat monoclonal
eBioscience

Catalog# 48-7311-82

Flow cytometry (1:100)

Antibody

Anti-Mouse Ly49A/D PE, rat
monoclonal

eBioscience

Catalog# 12-5783-81

Flow cytometry (1:100)

Antibody

Anti-Mouse Ly49D APC, rat
monoclonal

eBioscience

Catalog# 17-5782-82

Flow cytometry (1:100)

Antibody

Anti-Mouse Ly49E/F APC, rat
monoclonal

eBioscience

Catalog# 17-5848-80

Flow cytometry (1:100)

Antibody

Anti-Mouse Ly49I FITC, mouse
monoclonal

eBioscience

Catalog# 11-5895-82

Flow cytometry (1:100)

Antibody

Anti-Mouse CD94 FITC, rat
monoclonal

eBioscience

Catalog# 11-0941-82

Flow cytometry (1:100)

Antibody

Anti-Mouse NKG2A PerCP eFluor
710, mouse monoclonal

eBioscience

Catalog# 46-5897-82

Flow cytometry (1:100)

Antibody

Anti-Mouse TER-119 Biotin, rat
monoclonal

eBioscience

Catalog# 13-5921-85

Flow cytometry (1:100)

Antibody

Anti-Mouse CD117 APC, rat
monoclonal

eBioscience

Catalog# 17-1171-81

Flow cytometry (1:100)

Antibody

Anti-Mouse CD62L eFluor450, rat
monoclonal

eBioscience

Catalog# 48-0621-82

Flow cytometry (1:100)

Additional information

ES clone EPD0689_1_H03, ES line
JM8A3.N
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Appendix 1 Continued
Reagent type (species) or
resource
Designation

Source or
reference

Identifiers

Additional information

Antibody

Anti-Mouse CD122 eFluor 450, rat
monoclonal

eBioscience

Catalog# 48-1222-82

Flow cytometry (1:100)

Antibody

Anti-Mouse CD244.2 FITC, mouse
monoclonal

BD Pharmingen

Catalog# 553305

Flow cytometry (1:100)

Antibody

Anti-Mouse TCF-7/TCF-1 PE, mouse
monoclonal
BD Pharmingen

Catalog# 564217

Flow cytometry (1:100)

Antibody

Anti-Mouse Ly49F PE, mouse
monoclonal

BD Pharmingen

Catalog# 550987

Flow cytometry (1:100)

Antibody

Anti-Mouse CD122 FITC, rat
monoclonal

BD Pharmingen

Catalog# 553361

Flow cytometry (1:100)

Antibody

Anti-Mouse CD69 PE, armenian
hamster monoclonal

BD Pharmingen

Catalog# 553237

Flow cytometry (1:100)

Antibody

Anti-Mouse Ly49-G2 APC, rat
monoclonal

BD Pharmingen

Catalog# 555316

Flow cytometry (1:100)

Antibody

Anti-Mouse CD135 Brilliant Violet
421, rat monoclonal

Biolegend

Catalog# 135313

Flow cytometry (1:100)

Antibody

Anti-DYKDDDDK tag APC, rat
monoclonal

Biolegend

Catalog# 637307

Flow cytometry (1:100)

Antibody

Anti- DYKDDDDK tag PE, rat
monoclonal

Biolegend

Catalog# 637310

Flow cytometry (1:100)

Antibody

Anti-Mouse KLRG1 (MAFA) Biotin,
syrian hamster monoclonal

Biolegend

Catalog# 138406

Flow cytometry (1:100)

Antibody

Anti-Mouse CX3CR1 PE, mouse
monoclonal

Biolegend

Catalog# 149005

Flow cytometry (1:100)

Antibody

Anti-Mouse Ly49H Biotin, mouse
monoclonal

In-house

Flow cytometry (1:100)

Antibody

Anti-Mouse Ly49C Biotin, mouse
monoclonal

In-house

Flow cytometry (1:100)

Antibody

Anti-Mouse CD3 Biotin, armenian
hamster monoclonal

eBioscience

Catalog# 145–2C11

Flow cytometry (1:100)

Antibody

Anti-Mouse CD19 Biotin, rat
monoclonal

eBioscience

Catalog# 13-0193-85

Flow cytometry (1:100)

Antibody

Anti-Mouse
NK1.1 Biotin, mouse monoclonal

Biolegend

Catalog# 108704

Flow cytometry (1:100)

Antibody

Anti-Mouse CD11b Biotin, rat
monoclonal

Biolegend

Catalog# 101204

Flow cytometry (1:100)

Antibody

Anti-Mouse TER-119 Biotin, rat
monoclonal

eBioscience

Catalog# 13-5921-85

Flow cytometry (1:100)

Antibody

Anti-Mouse Ly-6G and Ly-6C Biotin,
rat monoclonal
BD Pharmingen

Catalog# 553125

Flow cytometry (1:100)

Antibody

Anti-Mouse
CD135 Biotin, rat monoclonal

BD Horizon

Catalog# 562537

Flow cytometry (1:100)

Antibody

Anti-Human/Mouse IRF8 APC,
mouse monoclonal

eBioscience

Catalog# 17-9852-82

Flow cytometry (1:100)

Antibody

Anti-Mouse Blimp-1 PE, rat
monoclonal

eBioscience

Catalog# 12-9850-82

Flow cytometry (1:100)

Antibody

Anti-Mouse Ki-67 eFluor, rat
monoclonal

eBioscience

Catalog# 48-5698-82

Flow cytometry (1:100)

Peptide, recombinant
protein

Streptavidin PerCP

BD Pharmingen

Catalog# 554064

Flow cytometry (1:200)

Peptide, recombinant
protein

Streptavidin PE

BD Pharmingen

Catalog# 554061

Flow cytometry (1:200)

Other

Fixable Viability Dye eFluor 506

eBioscience

Catalog# 65-0866-14

Flow cytometry (1:1000)

Antibody

Anti-FLAG M2-Peroxidase (HRP)
mouse monoclonal

Sigma

Catalog# A8592

Western blot (1:1000)
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Appendix 1 Continued
Reagent type (species) or
resource
Designation

Source or
reference

Identifiers

Additional information

Antibody

Beta-Actin antibody rabbit
polyclonal

Cell Signaling

Catalog# 4967S

Western blot (1:1000)

Antibody

Anti-rabbit IgG HRP-linked antibody
affinity purified from goat
Cell Signaling

Catalog# 7074S

Western blot (1:1000)

Commercial assay or kit

STEMCELL
EasySep Mouse NK cell isolation kit Technologies

Catalog# 19855

NK cell enrichment

Commercial assay or kit

PureLink RNA Mini Kit

Ambion

Catalog# 12183018A

RNA isolation

Sequence-based reagent

Tcf7

IDT DNA

Mm.PT.58.13528979

Fwd: CTTCAATCTGCTCATGCCCTA
Rev: TGTTCGTAGAGTGGAGAAAGC

Sequence-based reagent

Gzmb

IDT DNA

Mm.PT.58.42155916

Fwd: AAGAGAGCAAGGACAACACTC
Rev: CATGTCCCCCGATGATCTC

Mm.PT.58.30803964

Fwd: GCTCACATCTCCTTACATTTCCG
Rev:
TCCTCAAGCCGATCCAGTA

Sequence-based reagent

Klrg1

IDT DNA

Sequence-based reagent

Kit

IDT DNA

Mm.PT.58.33701407

Fwd: CGGCTAACAAAGGGAAGGAT
Rev:
GTATAAGTGCCTCCTTCTGTGC

Sequence-based reagent

Sell

IDT DNA

Mm.PT.58.13849728

Fwd: CTTCATTCCTGTAGCCGTCAT
Rev: CCATCCTTTCTTGAGATTTCTTGC

Sequence-based reagent

CD69

IDT DNA

Mm.PT.58.32284621

Fwd: ACGGAAAATAGCTCTTCACATCT
Rev: ACCACTATTAACACAGCCCAAG

Sequence-based reagent

Klrb1b

IDT DNA

Mm.PT.58.41786742

Fwd: CTAGCCAGGATCCAAGAACC
Rev: CAATCACGACCAGCACAAGA

Sequence-based reagent

Bhlhe41

IDT DNA

Mm.PT.31539347

Fwd: GGAACATAGGGATTTTATAG
GACTGG
Rev:
GCATTCATTAATTCGGTCTCGTC

Sequence-based reagent

Sox6

IDT DNA

Mm.PT.58.30547031

Fwd: CCGTACAGTTCATTCCGTCAA
Rev: GTCACTTATGCCCTTTAGCCT

Mm.PT.58.312575202

Fwd:
GAGACAAGAACCAAAAGCACAG
Rev:
GGAAAATGACAAGGAGAGCCA

Sequence-based reagent

Ccr7

IDT DNA

Sequence-based reagent

CD39

IDT DNA

Mm.PT.58.8557349

Fwd:
CGAGAAGGAGAATGACACAGG
Rev:
GTATCAGTTCGGTGGACAGTTC

Sequence-based reagent

Irf8

IDT DNA

Mm.PT.58.30819027

Fwd: TGTCTCCCTCTTTAAACTTCCC
Rev: GAAGACCATGTTCCGTATCCC

Mm.PT.58.43548565

Fwd:
GCTCCAATCTTGCAGTCGT
Rev:
CCTCTATCCTAGCTCATCTCCA

Mm.PT.58.17555544

Fwd:
TCCCTTCCCATCTGCTCA
Rev:
CACAATGTCGCCCAAATAACAG
Fwd: GAACCTGCTTTTCAAGTATGCTG
Rev:
TTCCCTTCGGTATGTACTCCT

Sequence-based reagent

Sequence-based reagent

Ccl5

Cx3cr1

IDT DNA

IDT DNA

Sequence-based reagent

Prdm1

IDT DNA

Mm.PT.58.10253822

Sequence-based reagent

Actb

IDT DNA

Fwd: GATTACTGCTCTGGCTCCTAG
Mm.PT. 39a.22214843.g Rev: GACTCATCGTACTCCTGCTTG

Sequence-based reagent

Bach2
Exon1-2

IDT DNA

Mm.PT.58.12332872

Fwd: TGTAGCCTTCTCATCTCTTCCT
Rev: ATCCACAGACATGCCGTTC

Sequence-based reagent

Bach2
Exon3-4

IDT DNA

Mm.PT.58.11332004

Fwd: GAAGCAGACAGTGAGTCGTG
Rev: ACTGTTCTGAGGTTAGCTTGTG

Sequence-based reagent

Bach2
Exon4-5

IDT DNA

Mm.PT.58.11289601

Fwd: GAGTTCATCCACGACATCCG
Rev: CAGTTTTTCCTTCTCGCACAC

Chemical compound,
drug

DNase

Sigma

Catalog# DN25
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Reagent type (species) or
resource
Designation

Source or
reference

Identifiers

Chemical compound,
drug

Hyaluronidase

Sigma

Catalog# H2126

Chemical compound,
drug

Liberase

Roche

Catalog# 05401119001

Peptide, recombinant
protein

Recombinant murine IL-15

PeproTech

Catalog# 210–15

Peptide, recombinant
protein

Recombinant murine IL-12 p70

PeproTech

Catalog# 200–12

Peptide, recombinant
protein

Recombinant mouse IL-18

MBL

Catalog# B002-5

Chemical compound,
drug

Calcein-AM

Biolegend

Catalog# 425201

Software, algorithm

Prism 9

GraphPad

https://www.graphpad.
com/

Software, algorithm

FlowJo 10

Treestar

https://www.flowjo.com/
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